-- Barnes & Noble, Humana, Sunoco: U.S. Equity Movers
-- B y   L u   W a n g
-- 2012-04-30T15:10:10Z
-- http://www.bloomberg.com/news/2012-04-29/exxon-mobil-gm-home-federal-merck-u-s-equity-preview.html
Shares of the following companies
are having unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are as of 10:50 a.m. in  New York .  Barnes & Noble Inc. (BKS)   surged 66 percent to $22.68
for the biggest increase in the Russell 2000 Index. A new
subsidiary that combines the bookseller’s Nook digital reader
and college businesses will receive a $300 million investment
from Microsoft Corp. (MSFT US).  Conceptus Inc. (CPTS)   rose 21 percent to $18.34 for the
biggest intraday gain since October 2008. The maker of a female-
sterilization method boosted its full-year sales forecast.  Demand Media Inc. (DMD)   rallied 23 percent to $8.90
after reaching $9.51, the highest intraday price since Aug. 15.
A deal by  Thomas H. Lee Partners  to take private the operator of
websites eHow.com and LiveStrong.com for $1.2 billion fell
apart, AllThingsD said, without saying where it got the
information.  Gen-Probe Inc. (GPRO)   climbed 19 percent, the most
intraday since April 2011, to $81.85. The developer of testing
for sexually transmitted disease agreed to be bought by  Hologic
Inc. (HOLX)   for about $3.7 billion in cash. Hologic slipped
8.9 percent to $19.34.  Harman International Industries Inc. (HAR)   increased 11
percent to $52.42 and jumped 12 percent earlier, the most
intraday since Oct. 21. The maker of audio equipment for cars
and homes reported third-quarter earnings excluding some items
of 74 cents a share, exceeding the average analyst estimate of
67 cents.  Humana Inc. (HUM)   declined 6.2 percent, the most in the
Standard & Poor’s 500 Index, to $82.36. The second-biggest
provider of U.S.-backed Medicare insurance said first-quarter
profit declined as premiums failed to keep up with rising
medical costs.  Imperial Holdings Inc. (IFT)   surged 33 percent to $3.91
after rallying as much as 40 percent, the most intraday since it
went public in February 2011. The specialty finance company
agreed to pay an $8 million penalty to resolve fraud allegations
related to its involvement in making misrepresentations on life
insurance applications, the Department of Justice said.  Merck & Co. (MRK)   rose the most in the  Dow Jones
Industrial Average , climbing 2 percent to $39.23. The
drugmaker’s subsidiaries won a patent-infringement case against
Sigma Pharmaceuticals Plc (SIP AU) over the importing of asthma
drugs from Poland to the U.K.  Sunoco Inc. (SUN)   climbed 19 percent to $48.81 for the
biggest advance in the  S&P 500 . The Philadelphia-based refinery
agreed to be acquired for $5.3 billion in shares and cash by
Energy Transfer Partners LP (ETP US), which is adding oil
transportation and distribution assets.  NYSE Euronext (NYX)   had the second-biggest decline in
the S&P 500, retreating 4.7 percent to $25.80. The largest U.S.
exchange operator reported a 44 percent decline in first-quarter
profit, as expenses related to its failed merger with Deutsche
Boerse AG combined with a slowdown in trading.  Sohu.com Inc. (SOHU)   dropped 8.1 percent to $51.27 after
sinking 10 percent earlier, the most intraday since Feb. 6. The
operator of  China ’s third-biggest online video site forecast
lower-than-expected growth in revenue this quarter as an
economic slowdown weakened online advertising sales.  Tenneco Inc. (TEN)   fell 9.6 percent to $33.63 after
erasing 11 percent earlier, the most intraday since Oct. 28. The
world’s largest maker of vehicle-exhaust systems reported first-
quarter earnings and revenue that fell short of the average
analyst estimates.  VeriFone Systems Inc. (PAY)   slipped 9 percent to $49.54
after sliding 11 percent earlier, the most intraday since May
12. The largest maker of credit-card terminals was cut to sell
from hold by Deutsche Bank AG.  Warner Chilcott Plc (WCRX)   gained 17 percent to $21.97
after jumping as much as 24 percent, the most intraday since
August 2009. The maker of dermatology and women’s health drugs
said it is exploring a sale of the company and is in talks with
potential buyers.  To contact the reporter on this story:
 Lu Wang  in New York at   lwang8@bloomberg.net .  To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  